Compile Data Set for Download or QSAR
maximum 50k data
Found 65 of ic50 data for polymerid = 50006826
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449871(US10703741, Compound I-14)
Affinity DataIC50:  550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449859(US10703741, Compound I-2)
Affinity DataIC50:  550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449862(US10703741, Compound I-5)
Affinity DataIC50:  550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449861(US10703741, Compound I-4 | US10703741, Compound I-...)
Affinity DataIC50:  550nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528716(US11198681, Compound I-43)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528721(US11198681, Compound I-48)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528692(US11198681, Compound I-19)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528749(US11198681, Compound I-73)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528747(US11198681, Compound I-71)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528746(US11198681, Compound I-70)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528744(US11198681, Compound I-69)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528743(US11198681, Compound I-68)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528741(US11198681, Compound I-66)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528737(US11198681, Compound I-62)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528728(US11198681, Compound I-55)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528701(US11198681, Compound I-28)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528703(US11198681, Compound I-30)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528710(US11198681, Compound I-37)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528711(US11198681, Compound I-38)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528712(US11198681, Compound I-39)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528754(US11198681, Compound I-78)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528723(US11198681, Compound I-50)
Affinity DataIC50:  3.00E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449858(US10703741, Compound I-1)
Affinity DataIC50:  5.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528750(US11198681, Compound I-74)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528705(US11198681, Compound I-32)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528682(US11198681, Compound I-9)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528748(US11198681, Compound I-72)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528693(US11198681, Compound I-20)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449865(US10703741, Compound I-8)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528742(US11198681, Compound I-67)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528719(US11198681, Compound I-46)
Affinity DataIC50:  7.50E+3nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449860(US10703741, Compound I-3)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449861(US10703741, Compound I-4 | US10703741, Compound I-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM449867(US10703741, Compound I-10)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528684(US11198681, Compound I-11)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528685(US11198681, Compound I-12)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528690(US11198681, Compound I-17)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528691(US11198681, Compound I-18)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528694(US11198681, Compound I-21)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528696(US11198681, Compound I-23)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528702(US11198681, Compound I-29)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528708(US11198681, Compound I-35)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528709(US11198681, Compound I-36)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528713(US11198681, Compound I-40)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528714(US11198681, Compound I-41)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528715(US11198681, Compound I-42)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528717(US11198681, Compound I-44)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528718(US11198681, Compound I-45)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528720(US11198681, Compound I-47)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein-arginine deiminase type-4(Mus musculus)
Padlock Therapeutics

US Patent
LigandPNGBDBM528722(US11198681, Compound I-49)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: